Latitude Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
Latitude Advisors's LLY Position: Q2 2026 in Review
Latitude Advisors increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $236K and bringing the position to 1,513 shares worth $1.82M. The position accounts for 0.72% of the portfolio, ranked #30.
Latitude Advisors first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.86M in Q1 2025. 2,134 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Latitude Advisors held 1,513 shares of Eli Lilly worth $1.82M as of Q2 2026.
- Latitude Advisors bought 231 Eli Lilly shares in Q2 2026, an estimated $236K.
- Eli Lilly made up 0.72% of Latitude Advisors's portfolio in Q2 2026, its #30 holding.
- Latitude Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
- Latitude Advisors's Eli Lilly position peaked at $1.86M in Q1 2025.
- 2,134 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Latitude Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.